Scholarship: Fully funded
Degree: bachelor or master
Nationality: International students
Application deadlines: January and August 2023
Professor Stanley Koo returned to his alma mater, The Chinese University of Hong Kong, as an Assistant Professor in the School of Biomedical Sciences at the end of 2019, and as a courtesy Assistant Professor in the Department of Obstetrics and Gynecology at The Prince of Wales Hospital, The Chinese University of Hong Kong. Dr. Gu is an expert member of the American College of Medical Genetics (FACMG), a member of the American Society of Human Genetics, and is certified in Clinical Molecular Genetics and Genomics and Clinical Cytogenetics and Genomics by the American Board of Medical Genetics and Genomics (ABMGG). Dr. Koo holds dual licenses in Clinical Molecular Genetics and Genomics and Clinical Cytogenetics and Genomics. Dr. Gu received his Ph.D. degree from the School of Biomedical Sciences, The Chinese University of Hong Kong in 2013 under the supervision of Prof. Weiyi Chen, the founding Dean of the School of Biomedical Sciences and the current Vice President. He was accepted by the American Society for Medical Genetics and Genomics in 2016, and received a three-year systematic training in the Genetic Diagnostics Laboratory at Baylor College of Medicine, and obtained a dual certification in Clinical Molecular Genetics and Clinical Cytogenetics in the United States in 2019. She has published more than 40 academic papers in high level international journals such as PLoS Genetics, Human Molecular Genetics, Genome Research, The American Journal of Human Genetics and Biomaterials. As of October 2022, the total number of citations of published papers is more than 1800, the Google Academic h index is 24, and the i10 index is 32.
Currently, the main research directions of the group are closely related to clinical patient samples, including: 1) exploring the pathogenic gene variants of rare genetic diseases using advanced tools such as exome and whole genome sequencing; 2) using the CRISPR system for precise gene editing, establishing cellular and animal models carrying patient-specific mutations, and deeply investigating the mechanism of pathogenic gene variants; 3) collaborating with Hong Kong Children’s Hospital to carry out The functional validation of variants of unknown significance to assist epileptic patients in selecting appropriate drugs. The research has received funding and support from the National Natural Science Foundation of China (NSFC), the University Grants Committee (RGC) and the Hong Kong Medical and Health Council (HMRF).
- Life science or medical related field
- bachelor or master degree in life science or medical related field, with research experience and publications preferred.
- PhD applications must meet the English language requirements of the Chinese University of Hong Kong: https://www.gs.cuhk.edu.hk/admissions/admissions/requirements
Please send your resume, undergraduate/master’s transcripts, research results/experience, language scores, published papers and other relevant information to [email protected].